Nestle

Nestle to keep Health Science unit after CEO's exit, chairman tells paper
Reuters
Sun, 08/25/24 - 11:04 pm
Nestle
Seres, indebted and in need of cash, agrees to sell microbiome pill to Nestle
BioPharma Dive
Thu, 06/6/24 - 11:46 am
Seres Therapeutics
microbiome
Nestle
C. difficile
Years after $2B buyout, Nestlé ditches Aimmune's peanut allergy drug Palforzia
Fierce Pharma
Tue, 09/5/23 - 11:32 am
Nestle
Palforzia
peanut allergy
M&A
Stallergenes Greer
FTC probes Abbott for allegedly colluding on bids for state contracts
Medical Marketing and Media
Wed, 05/24/23 - 11:27 am
Abbott Labs
Nestle
Reckitt Benckiser
collusion
FTC
state contracts
Nestlé to Sell Off Peanut Allergy Treatment, Not the Blockbuster They Hoped
Motley Fool
Tue, 11/29/22 - 11:00 pm
Nestle
peanut allergy
Aimmune Therapeutics
Palforzia
Nestlé wagers $41M on Enterome's preclinical food allergy and IBD prospect
Fierce Biotech
Mon, 07/18/22 - 10:00 am
Nestle
Enterome
food allergies
IBD
Opportunities arise for once-spurned partners
EP Vantage
Fri, 05/13/22 - 10:34 am
Pfizer
Biohaven
licensing
M&A
Aurinia
Bristol Myers Squibb
AbbVie
Alector
Arcus Biosciences
Biogen
Blueprint Medicines
CureVac
Gilead Sciences
GSK
Incyte
MorphoSys
Roche
Nestle
SAGE Therapeutics
Sarepta Therapeutics
Seres Therapeutics
Syndax
Leaps by Bayer backs a protein engineering startup taking on Aimmune — and Nestlé — in peanut allergy
Endpoints
Wed, 01/27/21 - 11:29 am
Bayer
Aimmune
peanut allergy
Ukko
Nestle
The top 10 largest biopharma M&A deals in 2020
Fierce Pharma
Tue, 01/19/21 - 10:30 am
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Gilead Sciences
Forty Seven
Merck
VelosBio
Nestle
Aimmune
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Bayer
Asklepios BioPharmaeutical
Aimmune Becomes Point Pharmaceutical Business for Nestlé
BioSpace
Wed, 10/14/20 - 05:47 pm
Nestle
Aimmune
M&A
food allergies
Gilead rescues biopharma’s takeout scene
EP Vantage
Wed, 10/7/20 - 11:02 am
M&A
Gilead Sciences
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Nestle
Aimmune
Tizona Therapeutics
The central figure in Nestlé's $2.6B Aimmune buyout? Covid-19
Endpoints
Tue, 09/15/20 - 11:01 am
Nestle
M&A
Aimmune
Palforzia
COVID-19
pandemic
peanut allergy
Nestle pays $2 billion to secure Aimmune’s allergy treatment
CNBC
Mon, 08/31/20 - 10:54 am
Aimmune
Nestle
M&A
peanut allergy
Palforzia
Armed with Nestlé cash, Aimmune grabs experimental food allergy drug form Xencor
Fierce Biotech
Wed, 02/5/20 - 09:58 am
Aimmune
Xencor
Nestle
AIMab7195
Palforzia
Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie
Xconomy
Mon, 01/27/20 - 10:57 am
Allergan
AbbVie
AstraZeneca
M&A
Nestle
Nestlé ups its bet on Aimmune’s peanut allergy drug to $276M as NDA filing looms, rivalry intensifies
Endpoints
Mon, 11/12/18 - 11:41 pm
Nestle
Aimmune Therapeutics
peanut allergy
Merck KGaA's consumer health sale at risk as Nestle bows out - sources
Yahoo/Reuters
Sat, 02/3/18 - 09:12 am
consumer health
M&A
Merck KGaA
Nestle
Nestlé determined to acquire Merck KGaA’s Consumer Health unit
GoinPharma
Mon, 12/4/17 - 09:35 am
Nestle
Merck KGaA
M&A
consumer health
Bayer, its consumer health ambitions snagged, recruits Nestle executive to replace current chief
Fierce Pharma
Wed, 11/15/17 - 11:04 am
Bayer
consumer health
Nestle
Nestle plans to ax hundreds of R&D staffers, shutter big dermatology campus
Endpoints
Thu, 09/21/17 - 08:45 am
R&D
layoffs
Galderma
Nestle
dermatology

Pages